Anteilseigner
Bratton Capital Management LP (10,78 %) Venrock Associates (6,10 %) The Vanguard Group, Inc. (3,54 %) Franklin Advisers, Inc. (2,44 %) Laurion Capital Management LP (1,70 %) Renaissance Technologies LLC (1,51 %) BlackRock Fund Advisors (1,42 %) Monashee Investment Management LLC (1,10 %) Invesco Capital Management LLC (0,99 %) Blue Owl Healthcare Opportunities Advisors LLC (0,96 %) Qube Research & Technologies Ltd. (0,93 %) Ghost Tree Capital LLC (0,77 %) Altium Capital Management LP (0,73 %) Keith J. Kendall (0,70 %) Essex Investment Management Co. LLC (0,67 %) Susquehanna Financial Group LLLP (0,66 %) Woodline Partners LP (0,66 %) Velan Capital Investment Management LP (0,66 %)
Kontakt
Aquestive Therapeutics Inc.